Hikma (Contract Manufacturing)

United States
Hybrid — also manufactures internal programs
Oral Solid Dose Oral Liquids Inhalation & Nasal Sterile Injectables Lyophilization Prefilled Syringes Cytotoxics
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
✓ FDA Inspections (3) ○ Clinical Trials ○ SEC Filings ○ Press ○ EMA GMP ○ MHRA GMP ✓ HC GMP (6)

Quick Facts: Hikma (Contract Manufacturing)

Signal Score
Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
Headquarters
United States
Website
Modalities
Oral Solid Dose, Oral Liquids, Inhalation & Nasal, Sterile Injectables, Lyophilization, Prefilled Syringes, Cytotoxics
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring

About Hikma (Contract Manufacturing)

Hikma (Contract Manufacturing) makes its own pharmaceutical products and also offers contract development and manufacturing services. Capabilities: Oral Solid Dose, Oral Liquids, Inhalation & Nasal, Sterile Injectables, Lyophilization, Prefilled Syringes, Cytotoxics. 4 manufacturing sites registered with the U.S. FDA and Health Canada. Website: https://www.hikma.com/what-we-do/contract-manufacturing/

Signal Score

Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works

Hikma (Contract Manufacturing) FDA Inspection History

2025-03
2023-04
2022-10
NAI VAI OAI
Date Site Type Observations Classification
2025-03-26
Thymoorgan Pharmazie Gmbh
Goslar Company-level
Drug Quality Assurance No Voluntary Action Indicated (VAI)
2023-04-25
Thymoorgan Pharmazie Gmbh
Goslar Company-level
Drug Quality Assurance Yes Voluntary Action Indicated (VAI)
2022-10-06
Thymoorgan Pharmazie Gmbh
Goslar Company-level
Drug Quality Assurance No Voluntary Action Indicated (VAI)
Source: FDA Data Dashboard · Retrieved Oct 31, 2026

Hikma (Contract Manufacturing) FDA 483 Findings 3 observations · 2023-04-25 → 2023-04-25 ?

By subsystem

  • Environmental Monitoring 1 (33.3%)
  • Documentation & Records 1 (33.3%)
  • CAPA 1 (33.3%)

By severity

  • 4 — Serious: 1
  • 3 — Moderate: 1
  • 2 — Minor: 1
  • Repeat observations: 0

Most severe findings

  • Serious (4) Environmental Monitoring 2023-04-25 21 CFR 211.42(c)(10)(iv)
    Environmental Monitoring System

    "Aseptic processing areas are deficient regarding the system for monitoring environmental conditions."

  • Moderate (3) CAPA 2023-04-25 21 CFR 211.192
    Investigations of discrepancies, failures

    "There is a failure to thoroughly review any unexplained discrepancy whether or not the batch has been already distributed."

  • Minor (2) Documentation & Records 2023-04-25 21 CFR 211.100(b)
    SOPs not followed / documented

    "Written production and process control procedures are not followed in the execution of production and process control functions and documented at the time of performance."

Hiring Activity Beta

Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source: public careers pages · Checked Oct 30, 2026

Frequently Asked Questions About Hikma (Contract Manufacturing)

How many FDA inspections does Hikma (Contract Manufacturing) have on record?
CDMO Signal tracks 3 FDA inspections for Hikma (Contract Manufacturing), sourced from the FDA inspection database. See the full inspection history above.
Has Hikma (Contract Manufacturing) received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Hikma (Contract Manufacturing).
Does Hikma (Contract Manufacturing) have a CDMO Signal Score?
Not yet. Hikma (Contract Manufacturing) is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating Hikma (Contract Manufacturing) for a manufacturing program?
Use the free AI matchmaker to compare Hikma (Contract Manufacturing) against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.

Similar CDMOs

AbbVie Contract Manufacturing
North Chicago, Illinois, United States
Small Molecule API, High-Potency APIs, Biologics, ADC / Bioconjugation, Sterile Fill-Finish, Lyophilization, Prefilled Syringes, Oral Solid Dose, Hot-Melt Extrusion, Oral Liquids, Topicals
Bayer Contract Manufacturing
Leverkusen, Germany
Oral Solid Dose, Non-sterile Liquids, Semi-solids & Liquids, Sterile Injectables, Lyophilization, Prefilled Syringes, Small Molecule API, High-Potency APIs, Microbial Fermentation
DMX Pharma
Milan, Italy
Oral Solid Dose, Oral Liquids, Semi-solids & Liquids, Softgels, Sterile Injectables, Inhalation & Nasal, Packaging & Labeling
Exela Pharma Sciences
Lenoir, North Carolina, United States
Sterile Injectables, Lyophilization, IV Bags, Prefilled Syringes
Gensenta (formerly Mustafa Nevzat)
Istanbul, Turkey
Sterile Injectables, Lyophilization, Oral Solid Dose, Oncology Products, Small Molecule API

Compare Hikma (Contract Manufacturing) with another CDMO

Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.
Compare side-by-side
See two CDMOs' scoring, inspection history, and clinical footprint next to each other.
Open comparison →
Run a sourcing search
Describe your program's requirements — Signal matches CDMOs against FDA, EMA/MHRA, ClinicalTrials.gov and capacity signals.
Search for a CDMO →
Get updates on Hikma (Contract Manufacturing)
Get an email when a CDMO on this list has a new FDA inspection, GMP certificate, or scoring change.